Hypertension Drug's Labeling Problems Prompt GSK Recall
GlaxoSmithKline PLC will recall some 394,000 bottles of a blood-pressure medication in the U.S. after drug labeling problems were revealed at a Novartis AG plant in Nebraska that supplies the medication,...To view the full article, register now.
Already a subscriber? Click here to view full article